Exploratory Reta stack
MOTS-c cellular and animal studies alongside a separate metabolic-receptor record.
Community-referenced selection · combination unvalidated
No supporting controlled human study of this exact combination was identified in our September 5, 2026 review. Safety and efficacy together are unestablished. The MOTS-c source studies it independently. It does not demonstrate additional energy, fat loss, fuel utilization or compatibility when combined with the anchor compound.
Collects receptor pharmacology and the separate literature on the mitochondrial-derived peptide MOTS-c. Retatrutide is the only metabolic-receptor anchor in this collection. Each material remains a separate product record.
Published findings concern the stated study materials and models. They do not establish the exact catalog combination.
Individual product records, together for review.
1 vial
$120
PDL-RT3 is the catalog alias for a synthetic peptide analogue in the triple incretin-receptor research class. Its laboratory record identifies the underlying analyte separately, while the catalog material is supplied as a sealed vial of lyophilized powder for analytical research.
Lot documentation published
1 vial
$45
MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S ribosomal RNA gene. Its name abbreviates mitochondrial open reading frame of the 12S rRNA type-c, and the catalog material is supplied as lyophilized powder in a sealed vial.
Lot documentation published
One vial of each included product.
Individual value: $165Save $15
Ask about Reta + MOTS-c
Contact us for current availability and lot documentation for the products in this selection.
Laboratory research only. Goal labels describe research themes, not promised outcomes or combined-use guidance. Each product is a separate catalog record. Not for human or veterinary use.